- THIS ARTICLE
-
Abstract
- Full Text (PDF)
- Alert me when this article is cited
- Alert me if a correction is posted
- SERVICES
- Similar articles in this journal
- Similar articles in PubMed
- Alert me to new issues of the journal
- Download to citation manager
- Reprints & Permissions
- CITING ARTICLES
- Citing Articles via HighWire
- Citing Articles via Google Scholar
- GOOGLE SCHOLAR
- Articles by Tracey, W. D.
- Articles by Gergen, J. P.
- Search for Related Content
- PUBMED
- PubMed Citation
- Articles by Tracey, W. D., , Jr.
- Articles by Gergen, J. P.
Quantitative Analysis of Gene Function in the Drosophila Embryo
William D. Tracey, Jr.a, Xiangqun Ninga, Martin Klingler1,a, Sunita G. Kramer2,a, and J. Peter Gergenaa Department of Biochemistry and Cell Biology and the Institute for Cell and Developmental Biology, State University of New York, Stony Brook, New York 11794-5215
Corresponding author: J. Peter Gergen, Department of Biochemistry and Cell Biology, SUNY, Stony Brook, NY 11794-5215., pgergen{at}life.bio.sunysb.edu (E-mail)
Communicating editor: T. C. KAUFMAN
| ABSTRACT |
|---|
The specific functions of gene products frequently depend on the developmental context in which they are expressed. Thus, studies on gene function will benefit from systems that allow for manipulation of gene expression within model systems where the developmental context is well defined. Here we describe a system that allows for genetically controlled overexpression of any gene of interest under normal physiological conditions in the early Drosophila embryo. This regulated expression is achieved through the use of Drosophila lines that express a maternal mRNA for the yeast transcription factor GAL4. Embryos derived from females that express GAL4 maternally activate GAL4-dependent UAS transgenes at uniform levels throughout the embryo during the blastoderm stage of embryogenesis. The expression levels can be quantitatively manipulated through the use of lines that have different levels of maternal GAL4 activity. Specific phenotypes are produced by expression of a number of different developmental regulators with this system, including genes that normally do not function during Drosophila embryogenesis. Analysis of the response to overexpression of runt provides evidence that this pair-rule segmentation gene has a direct role in repressing transcription of the segment-polarity gene engrailed. The maternal GAL4 system will have applications both for the measurement of gene activity in reverse genetic experiments as well as for the identification of genetic factors that have quantitative effects on gene function in vivo.
THE Drosophila embryo provides a remarkable demonstration of the productive interplay between developmental genetics and mechanistic studies on gene function. For example, the central role of transcriptional regulation in patterning the embryo resulted from studies on genes identified through the pioneering mutational studies of ![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
We have been using the Drosophila embryo as a model to investigate the function of the pair-rule segmentation gene runt. Runt is the founding member of the Runt domain family of transcriptional regulators (![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
In Drosophila, runt is required for the proper transcriptional regulation of a number of different genes during early embryogenesis. In some instances runt functions to activate transcription (![]()
![]()
![]()
![]()
![]()
![]()
![]()
The modular GAL4 system is an alternative and important tool that has been developed for the manipulation of gene expression in Drosophila (![]()
![]()
![]()
![]()
![]()
![]()
Here we describe a system that allows for GAL4-driven ectopic expression in the early embryo. We constructed a GAL4 expression vector that uses the promoter from the maternally expressed gene nanos and a 3' untranslated (UTR) region from a tubulin mRNA to drive maternally dependent uniform activation of GAL4-dependent transgenes during the blastoderm stage of embryogenesis. Through the use of NGT (nanos-GAL4-tubulin) lines that have different levels of GAL4 activity, it is possible to quantitatively manipulate expression in the embryo over a range that extends up to an estimated 125,000 molecules/blastoderm cell. Specific phenotypes are produced by expression of different developmental regulators with this system, including genes that normally do not function during embryogenesis. We further characterized the use of this system for the analysis of runt function. Importantly, all of the targets identified as being subject to regulation by runt using the heat-shock assay system also respond when runt expression is driven with the maternal GAL4 system. However, experiments with the GAL4 system reveal clear quantitative differences in the sensitivity of different targets. The potential applications of this system for quantitative studies of gene function in the Drosophila embryo are discussed.
| MATERIALS AND METHODS |
|---|
Plasmid construction:
A CaSpeR P-element transformation vector was constructed that contains the coding region of yeast GAL4 immediately downstream of the nanos promoter and upstream of DNA containing the 3' UTR of the Drosophila
Tub84B gene. The nanos promoter and ~250 bp of 5' UTR are contained in a 1.1-kb HindIII + NdeI restriction fragment that was isolated from plasmid pBS-P[nos], generously provided by L. Gavis (Princeton University). One step of the cloning strategy included destruction of an initiator methionine for the Nanos protein that is encoded at the NdeI site of this fragment. The GAL4-encoding fragment was isolated as a HindIII fragment from plasmid pGAT-B (![]()
Tub84B 3' UTR was contained within an 850-bp XhoI + HindIII fragment from plasmid pT
1-5'-3' (![]()
![]()
A UAS-runt construct was made by cloning a 3.2-kb BamHI fragment isolated from pCaSpeR:hs-runt (![]()
![]()
Fly strains and crosses:
Drosophila strains were maintained on standard cornmeal/yeast/sugar and agar media. General information on marker mutations and balancer chromosomes is available through ![]()
2-3 helper plasmid. The P{UAS-runt.T}232 line was recovered as 1 of 14 initial independent lines and was retained as a representative strong line based on experiments with a Kr-GAL4 driver (M. KLINGLER and J. P. GERGEN, unpublished results). Preliminary characterization based on the lethality obtained with various UAS transgenes indicated that 2 of the initial NGT lines, P{GAL4-nos.NGT}9 and P{GAL4-nos.NGT}11, had the highest levels of activity. These 2 lines were mapped to the third and second chromosomes, respectively, and stocks homozygous for each of these chromosomes were established. P-transposition mediated by the
2-3 third chromosome (![]()
Flies carrying an X-chromosome-linked transposon for GAL4-dependent expression of lozenge (lz) were obtained from Utpal Banerjee (UCLA). The UAS transgenes for expression of lacZ (P{UAS-lacZ.B}4-1-2), decapentaplegic (dpp, P{UAS-dpp.S}42B.4), en (P{UAS-en.Y}4-1), and the different isoforms of pointed (pnt[P1], P{UAS-pnt.P1}3), and pnt[P2], P{UAS-pnt.P2}2) were obtained from the Bloomington stock center. The transposon for the P{UAS-runt.T}232 line maps on chromosome II and is homozygous viable. The P{UAS-runt.T}U15 line, which also maps on chromosome II, was generated by
2-3-mediated mobilization. Quantitation by RNase protection indicates that the U15 line is expressed at approximately threefold higher levels than the 232 line (![]()
Embryo manipulation:
For cuticle preparations, nonhatching embryos were dechorionated in bleach, rinsed with distilled water, and mounted in a 1:1 mixture of lactic acid and Hoyer's. In situ hybridization was carried out as described previously (![]()
![]()
The quantitative measurement of ß-galactosidase activity was done using a luminescent substrate and the Galacto-Light Plus detection kit (Tropix, Bedford, MA). Single living embryos of the appropriate stage were identified by observation under oil (Halocarbon Products), transferred into a microfuge tube, and homogenized in 50 µl of lysis buffer (100 mM potassium phosphate, pH 7.8, 0.2% Triton X-100, 1 mM dithiothreitol, 100 µg/ml bovine serum albumin). One-fifth of this homogenate was diluted into 70 µl of reaction buffer (100 mM sodium phosphate, pH 8.0, 1 mM magnesium chloride) containing a 1:100 dilution of the Galacto-Light Plus substrate stock solution (Tropix) and incubated at room temperature for 3060 min. Activity was measured after addition of 100 µl of Light Emission Accelerator (Tropix) containing 10 mM H2O2 on an Optocomp I luminometer (MGM Instruments, Inc.). The relative light units reported were all from readings taken over a 30-sec interval. This assay was calibrated by adding purified ß-galactosidase (Sigma, St. Louis) into extracts of control embryos. The assay was linear over the full range tested, from 0.46 to 330 pg with an average measurement of 15 x 103 light units/pg of enzyme.
| RESULTS |
|---|
A maternal effect GAL4 mRNA:
The two-component GAL4 system (![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
Tub84B gene. nos is specifically expressed in germ cells with high expression levels in the ovary in germ-line cysts from region 2 of the germarium (![]()
![]()
Tub84B gene product is abundant during both oogenesis and early embryogenesis (![]()
|
A number of transgenic lines carrying the P{GAL4-nos.NGT} were obtained by P-element-mediated germ-line transformation. P-element remobilization was also used to obtain additional derivatives of these initial lines. Characterization of these lines by a number of criteria indicated that they did indeed express GAL4 maternally, and that there were differences in the level of expression in the different lines. We used P{GAL4-nos.NGT}40, a relatively strong line (see below), to investigate the activity of the NGT transgenes. In situ hybridization reveals that embryos derived from homozygous P{GAL4-nos.NGT}40 females express a paternally inherited UAS-lacZ reporter gene during the syncytial blastoderm stage, prior to cellularization (Fig 2B). Expression is observed at uniform levels throughout the embryo with the exception that no lacZ mRNA accumulates within the pole cells (Fig 2C). Expression levels increase through the completion of cellularization, gastrulation, and the process of germband extension (Fig 2D and Fig E). Reciprocal matings between females that are homozygous for the UAS-lacZ transgene and homozygous P{GAL4-nos.NGT}40 males confirm that NGT-driven expression is strictly maternally dependent. Thus, the increasing accumulation of UAS-lacZ mRNA during the postblastoderm stages is due to perduring maternal GAL4 activity at either the mRNA and/or protein level.
|
A sensitive photometric assay for ß-galactosidase activity was used to quantitate the levels of NGT-driven gene expression. This assay used a luminescent substrate that allows for detection of UAS-lacZ expression in aliquots of extracts prepared from single embryos (see MATERIALS AND METHODS). To generate a developmental time course, we performed assays on single embryos that were staged based on the time at which they initiated gastrulation. This is a readily observed and rapid morphogenetic process that occurs immediately upon completion of cellularization. The activity detected in early gastrula stage embryos is >100-fold greater than the background levels detected in control crosses (Table 1). This enzyme activity depends on not only transcription of the P{UAS-lacZ.B} transgene, but also translation of the lacZ mRNA prior to the completion of cellularization. Calibration experiments indicate that the level of activity detected per embryo at this stage is equivalent to that of 67 pg of ß-galactosidase. This corresponds to ~1.25 x 105 molecules of ß-galactosidase in each of the 6000 blastoderm cells. As found for the mRNA, ß-galactosidase enzyme levels continue to increase during the germband extension stages (Table 1). Decreases in enzyme activity levels, which require degradation of both the lacZ mRNA and protein, do not become apparent until several hours later, when the embryos are in the process of germband retraction.
|
Unique phenotypes produced by NGT-driven expression of different UAS transgenes:
We examined the effects of using the strong P{GAL4-nos.NGT}40 line to drive expression of several different UAS transgenes in the blastoderm embryo. Embryonic lethality was observed for all but one of the different UAS lines tested. Cuticle preparations of the inviable embryos indicate that unique phenotypes are associated with NGT-driven expression of each of these genes. Ectopic expression of dpp produces embryos that lack ventral denticle belts (Fig 3A). This resembles the phenotypes obtained when dpp is ectopically expressed by other means in the early embryo and is consistent with the role that dpp has in dorsal-ventral patterning (![]()
![]()
![]()
|
We also obtained specific embryonic lethal phenotypes upon ectopic expression of lz and pnt, two genes that are most well characterized for their roles in pattern formation during eye development (![]()
![]()
![]()
![]()
![]()
![]()
Quantitative effects of NGT-driven expression:
The above experiments are with P{GAL4-nos.NGT}40, one of the stronger maternal GAL4 drivers. We also examined the activities of other lines using similar assays. The results for three representative lines, P{GAL4-nos.NGT}11, P{GAL4-nos.NGT}31, and P{GAL4-nos.NGT}40, are shown in Table 2. Quantitation of ß-galactosidase activity allows for a direct measurement of the relative levels of expression produced by these different lines. Even a single copy of P{GAL4-nos.NGT}11, the weakest line characterized in these experiments, drives expression of lacZ at levels that are 100-fold over background. The maternal effects are additive, as females that are homozygous for any particular NGT chromosome show approximately twice the level of activity as heterozygous females (Table 2). The relative strengths of these different NGT genotypes correlate with the lethality observed in crosses with different UAS transgenes (Table 2). Importantly, these data show that for a number of the toxic UAS transgenes tested in our assays, the difference between no discernible effect on viability and fully penetrant embryonic lethality occurs over a range that involves only a 4- to 5-fold increase in the level of NGT-driven expression.
|
We further characterized the basis of the lethality obtained in crosses with UAS-runt. One observation of particular interest was a pronounced sex bias in lethality that was not obtained with the other UAS transgenes. Males are consistently more sensitive than females to the lethal effects of NGT-driven runt expression. One explanation for this sex-biased lethality is that NGT-driven runt expression leads to inappropriate activation of the Sex-lethal (Sxl) gene in male embryos. This would be consistent with runt's role as a regulator of Sxl and would both confirm and extend recent results indicating that increased runt activity can result in transcriptional activation of Sxl in male embryos (![]()
An alternative explanation is that the activity of the P{UAS-runt.T} transgene is dosage compensated, i.e., it is twice as active in males as in females. Using the results of the ß-galactosidase assays as a scale, we estimate that males are approximately twice as sensitive as females to the toxic effects of runt overexpression. For example, male viability is reduced to 10% in crosses with heterozygous P{GAL4-nos.NGT}31 mothers. A comparable reduction in female viability is obtained in crosses either with heterozygous P{GAL4-nos.NGT}40 mothers or with homozygous P{GAL4-nos.NGT}31 mothers. These two maternal genotypes are estimated to have twice the activity of the heterozygous P{GAL4-nos.NGT}31 mothers (Table 2). Similarly, fully penetrant lethality of the P{UAS-runt.T} transgene in males is obtained at half the level of NGT activity that is required for fully penetrant lethality in females (homozygous P{GAL4-nos.NGT}11 females vs. homozygous P{GAL4-nos.NGT}40 females, respectively). These results agree extremely well with a model whereby the embryonic activities of the P{UAS-runt.T} transgenes are dosage compensated. Previous work demonstrated that runt's activity during segmentation is dosage compensated (![]()
Quantitative response of target genes to UAS-runt during segmentation:
The expression of genes in both the pair-rule and segment-polarity classes of segmentation genes is altered in runt mutant embryos (![]()
![]()
![]()
![]()
![]()
![]()
![]()
We examined the response of several segmentation genes to different levels of NGT-driven runt expression. To obtain insight on the basis for the lethality associated with NGT-driven runt expression, we examined embryos from a cross of homozygous P{GAL4-nos.NGT}11 females with homozygous P{UAS-runt.T} males. The level of UAS-runt activity in embryos from this cross is fully lethal to males and allows for only limited female viability (Table 2). Embryos from this cross show a consistent repression of the odd-numbered stripes of the segment-polarity gene en (Fig 4F). In contrast, expression of the pair-rule genes eve and ftz is not altered in these same embryos (Fig 4G and Fig H). Similarly, this level of ectopic runt activity has little to no effect on the expression of the pair-rule genes hairy, paired, odd-skipped, and sloppy-paired (data not shown). This strongly suggests that the repression of en is not mediated indirectly through alterations in the expression of these other pair-rule genes, and it provides evidence that runt directly represses the odd-numbered en stripes. As expected, some variation is also observed in the patterns of en expression. All embryos show defects in the initiation of the odd-numbered stripes during the early stages of germband extension. In later stage embryos, the expression of the odd-numbered en stripes is partially or even fully restored. Approximately 10% of the embryos at full germband extension show apparently normal en expression. This corresponds well to the proportion of progeny from this cross that will survive to adulthood.
|
We also examined segmentation gene expression patterns in embryos from a cross of homozygous P{GAL4-nos.NGT}40 females with homozygous P{UAS-runt.T}U15 males. This combination is estimated to allow for an approximately sixfold higher level of ectopic expression than that obtained in the above experiment and is equal to or greater than that obtained within the pair-rule stripes produced by the endogenous runt gene (Fig 4I). As observed at lower levels, the odd-numbered stripes of en are repressed by this higher level of ectopic runt expression (Fig 4J). The effects of high-level NGT-driven runt expression on the pair-rule genes mimic what has been described previously in hs-runt embryos. Expression of eve is reduced and there is a difference in the sensitivity of the different stripes, stripe 2 being the most sensitive to repression by runt (Fig 4K). Similar stripe-specific repression of hairy stripe #1 is also observed in these embryos (data not shown). Expression of ftz is increased with the broader stripes fusing, especially in the more posterior regions (Fig 4L). These findings validate previous results with hs-runt embryos and indicate that these different regulatory interactions are not a result of the physiological perturbations associated with the heat-shock response. The localized effects of NGT-driven runt expression on the pair-rule genes contrast with the relatively uniform repression of the odd-numbered en stripes. This provides a further indication that the repression of en is direct and not mediated by other pair-rule genes.
| DISCUSSION |
|---|
A maternal GAL4 system:
We have developed and characterized Drosophila strains that express the yeast transcription factor GAL4 maternally. These strains fill a void in the collection of GAL4 drivers that are available for manipulating gene expression in Drosophila. Many of the GAL4 lines that have been characterized previously are based on the initial expression constructs of ![]()
Tub84B mRNA in place of the hsp70 terminator. The use of the tubulin 3' UTR also distinguishes the NGT strains from GAL4 drivers that use the 3' UTRs of either bicoid (![]()
![]()
The importance of mRNA control elements in GAL4 misexpression strategies is also reemphasized by the recent work of ![]()
![]()
There are several attractive features of using maternally driven GAL4 expression to investigate gene function. First, the large body of information on the genetics and cell biology of the Drosophila embryo makes this a powerful developmental context for interpreting the phenotypes produced by ectopic expression of any target gene of interest. Experiments at this stage of development also avoid some of the difficulties that can arise with other GAL4 drivers that have low levels of expression at stages or in tissues other than the desired developmental context. With a maternal GAL4 driver, the earliest stage at which a paternally inherited UAS transgene is available for activation by GAL4 protein is within the fertilized egg. Finally, the relative simplicity of the ectopic expression pattern makes it relatively straightforward to interpret the experimental results quantitatively. The three NGT lines characterized here allow for control of expression over a range that differs >10-fold between the weakest line as a heterozygote and the strongest line as a homozygote (Table 2). Using enzyme activity measurements as a benchmark, we estimate this range to extend from ~10,000 to 125,000 molecules of ß-galactosidase/cell at the blastoderm stage. Table 2 does not include data from other, weaker lines. It is also possible to obtain higher expression levels by combining different NGT drivers. Altogether, with the NGT lines that are currently available, we estimate being able to manipulate expression levels over a range that approaches two orders of magnitude.
The expression levels obtained with the different NGT drivers are presumed to be due to the sites of transgene insertion. Similar position effects are, of course, also observed for different inserts of any given UAS transgene. Indeed, the ability to mix and match NGT drivers with different UAS responders provides an additional level of flexibility that can be useful in the design and interpretation of ectopic expression experiments. Our experiences with several different P{UAS-runt.T} lines indicate a robust and linear response over the ranges tested. The phenotype observed in any given cross depends on the level of runt expression that is obtained, irrespective of the particular combination of NGT driver and UAS-runt responder that is used in the cross.
There is an additional point to be made with respect to our attempts to quantitatively characterize this ectopic expression assay system. As indicated in the tables, the standard error in the measurements of NGT-driven ß-galactosidase activity averages ~20% of the activity measured, irrespective of the total absolute enzyme activity. These assays were carried out on individual embryos that were staged based on their time of gastrulation, a readily observed and rapid morphogenetic change that immediately follows the completion of cellularization. Thus, the embryo-to-embryo variability is not likely to be due to differences in developmental stage. Repeated measurements on extracts from different single embryos further indicate that differences in micropipeting do not account for this level of variability. Thus, the variability may be intrinsic within this biological system. This variation somewhat complicates the utility of this system for confident measurement of small (<20%) changes in the level of gene function. However, the ability to manipulate gene expression in a stepwise manner over one to two orders of magnitude with a reliability that approaches ±20% will provide an important tool for quantitative analysis of gene function in vivo. Indeed, the importance of quantitative considerations is emphasized by the dose-dependent effects obtained with several different toxic UAS transgenes. In each case we found a relatively sharp threshold in the biological response, with the difference between no apparent phenotype and a nearly fully penetrant, lethal phenotype resulting from a four- to fivefold increase in the level of NGT-driven ectopic gene expression.
Interactions between runt and the sex determination pathway:
Our results reveal that male embryos are reproducibly more sensitive than females to the toxic effects of UAS-runt expression. Previous work reveals there are multiple interactions between runt and the sex determination system in Drosophila. The master regulator in the sex determination pathway is the Sxl gene, which normally is activated in females and repressed in males. runt plays a role in the transcriptional activation of Sxl, and increasing the dosage of runt activity is sufficient for triggering the inappropriate activation of Sxl in preblastoderm male embryos (![]()
The preferential sensitivity of males to NGT-driven runt expression is readily explained if P{UAS-runt.T} activity is dosage compensated. A comparison of the NGT expression levels required to produce comparable effects on male and female viability is consistent with a twofold increase in UAS-runt potency in males. These observations provide the basis for a model in which Sxl, which is specifically expressed in females, buffers the embryos from the toxic effects of UAS-runt expression. In addition to its more widely known role in regulating splicing, the Sxl protein represses expression of msl-2 by interacting directly with the 5' and 3' UTR of the msl-2 mRNA (![]()
![]()
![]()
Dose-dependent effects of runt on segmentation:
The Runt protein is a pivotal transcriptional regulator in the pathway of segmentation in Drosophila. Previous work with heat-inducible hs-runt transgenes has indicated that Runt functions to activate the transcription of some downstream targets, such as ftz, while repressing the transcription of targets such as en, eve, and hairy (![]()
![]()
![]()
![]()
![]()
What is the relevance of runt's ability to repress the odd-numbered en stripes for normal segmentation? The even- and odd-numbered en stripes are controlled by two distinct regulatory programs (![]()
![]()
![]()
![]()
Among the segmentation genes examined here, en is the most sensitive to ectopic runt expression. Indeed, the threshold response of en correlates extremely well with the threshold for the lethality that is associated with NGT-driven runt expression. This lethal phenotype provides a powerful entry point for a genetic dissection of Runt function. One approach is to screen for mutations that suppress the lethality associated with runt overexpression during this early stage of embryogenesis. There is an obvious practical advantage of genetic screens that are based on suppression of a lethal phenotype. There is also an important theoretical advantage of this kind of approach compared to sensitized screens that are based on the enhancement of intermediate mutant phenotypes. Mutations with generally deleterious effects would be expected to increase the severity of defects in a sensitized genetic screen based on enhancement of loss-of-function phenotypes, but in a nonspecific manner. However, these same mutations also would be expected to enhance, not suppress, the severity of defects produced by GAL4-driven overexpression. From our quantitative analysis, we feel it should be possible to identify and characterize mutations that have a twofold effect on the potency of the Runt protein. In summary, the ability to quantitatively manipulate gene expression in the Drosophila blastoderm embryo should provide a powerful new tool for genetic studies on the function of runt as well as any other regulatory gene product that can function within this well-defined developmental context.
| FOOTNOTES |
|---|
1 Present address: Zoologisches Institut der Universität München, Luissenstrasse 14, 80333 Munich, Germany. ![]()
2 Present address: Department of Molecular and Cell Biology, 519 Life Sciences Addition, University of California Berkeley, Berkeley, CA 94720. ![]()
| ACKNOWLEDGMENTS |
|---|
The excellent and invaluable technical assistance of Claudia Brunner and Deborah Swantek is greatly appreciated. Joe McLean provided the impetus and some assistance with cuticle preparations of embryos carrying various UAS transgenes. This manuscript was improved by comments from John Wheeler, Kathy Wojtas, and Christine VanderZwan. Recombinant DNA plasmids containing the nos promoter and the
Tub84B 3' UTR were generous gifts from Liz Gavis (Princeton, NJ) and Bill Theurkauf (University of Massachusetts), respectively. The starting vectors for the GAL4 modular misexpression system, pGAT-B and pUAS-T, were provided by Andrea Brand (Welcome MRC Institute, Cambridge, United Kingdom). The P{UAS-lz} flies were a gift from Utpal Banerjee (UCLA). Sxl mutations were obtained from Tom Cline (Berkeley) and Jim Ericson (Columbia). Many of the other Drosophila lines used in this work were obtained from the stock center in Bloomington. This work was supported by a National Institutes of Health grant GM-53229 to J.P.G.
Manuscript received July 8, 1999; Accepted for publication September 15, 1999.
| LITERATURE CITED |
|---|
AL-ATIA, G. R., P. FRUSCOLONI, and M. JACOBS-LORENA, 1985 Translational regulation of mRNAs for ribosomal proteins during early Drosophila development. Biochemistry 24:5798-5803[Medline].
ARNOSTI, D. N., S. BAROLO, M. LEVINE, and S. SMALL, 1996 The eve stripe 2 enhancer employs multiple modes of transcriptional synergy. Development 122:205-214[Abstract].
ARONSON, B. D., A. L. FISHER, K. BLECHMAN, M. CAUDY, and J. P. GERGEN, 1997 Groucho-dependent and -independent repression activities of Runt domain proteins. Mol. Cell. Biol. 17:5581-5587[Abstract].
BASHAW, G. J. and B. S. BAKER, 1997 The regulation of the Drosophila msl-2 gene reveals a function for Sex-lethal in translational control. Cell 89:789-798[Medline].
BAUMGARTNER, S. and M. NOLL, 1990 Network of interactions among pair-rule genes regulating paired expression during primordial segmentation of Drosophila. Mech. Dev. 33:1-18[Medline].
BRAND, A. H. and N. PERRIMON, 1993 Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. Development 118:401-415[Abstract].
BRUNNER, D., K. DUCKER, N. OELLERS, E. HAFEN, and H. SCHOLZ et al., 1994 The ETS domain protein pointed-P2 is a target of MAP kinase in the sevenless signal transduction pathway. Nature 370:386-389[Medline].
CARROLL, S. B. and M. P. SCOTT, 1986 Zygotically active genes that affect the spatial expression of the fushi tarazu segmentation gene during early Drosophila embryogenesis. Cell 45:113-126[Medline].
DAGA, A., C. A. KARLOVICH, K. DUMSTREI, and U. BANERJEE, 1996 Patterning of cells in the Drosophila eye by Lozenge, which shares homologous domains with AML1. Genes Dev. 10:1194-1205
DINARDO, S. and P. H. O'FARRELL, 1987 Establishment and refinement of segmental pattern in the Drosophila embryo: spatial control of engrailed expression by pair-rule genes. Genes Dev. 1:1212-1225
DINARDO, S., E. SHER, J. HEEMSKERK-JONGENS, J. A. KASSIS, and P. H. O'FARRELL, 1988 Two-tiered regulation of spatially patterned engrailed gene expression during Drosophila embryogenesis. Nature 332:604-609[Medline].
DONG, J., L. H. HUNG, R. STROME, and H. M. KRAUSE, 1998 A phosphorylation site in the ftz homeodomain is required for activity. EMBO J. 17:2308-2318[Medline].
DORMAND, E. L. and A. H. BRAND, 1998 Runt determines cell fates in the Drosophila embryonic CNS. Development 125:1659-1667[Abstract].
DUCY, P., R. ZHANG, V. GEOFFROY, A. L. RIDALL, and G. KARSENTY, 1997 Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 89:747-754. [see comments][Medline].
DUFFY, J. B. and J. P. GERGEN, 1991 The Drosophila segmentation gene runt acts as a position-specific numerator element necessary for the uniform expression of the sex-determining gene Sex-lethal.. Genes Dev. 5:2176-2187
DUFFY, J. B., M. A. KANIA, and J. P. GERGEN, 1991 Expression and function of the Drosophila gene runt in early stages of neural development. Development 113:1223-1230[Abstract].
EPHRUSSI, A. and R. LEHMANN, 1992 Induction of germ cell formation by oskar. Nature 358:387-392. [see comments][Medline].
FERGUSON, E. L. and K. V. ANDERSON, 1992 Decapentaplegic acts as a morphogen to organize dorsal-ventral pattern in the Drosophila embryo. Cell 71:451-461[Medline].
FISCHER, J. A., E. GINIGER, T. MANIATIS, and M. PTASHNE, 1988 GAL4 activates transcription in Drosophila. Nature 332:853-856[Medline].
FITZPATRICK, V. D., A. PERCIVAL-SMITH, C. J. INGLES, and H. M. KRAUSE, 1992 Homeodomain-independent activity of the fushi tarazu polypeptide in Drosophila embryos. Nature 356:610-612[Medline].
FLORES, G. V., A. DAGA, H. R. KALHOR, and U. BANERJEE, 1998 Lozenge is expressed in pluripotent precursor cells and patterns multiple cell types in the Drosophila eye through the control of cell-specific transcription factors. Development 125:3681-3687[Abstract].
FLYBASE,, 1999 The FlyBase database of the Drosophila Genome Projects and community literature. The FlyBase Consortium. Nucleic Acids Res. 27:85-88.
FORBES, A. and R. LEHMANN, 1998 Nanos and Pumilio have critical roles in the development and function of Drosophila germline stem cells. Development 125:679-690[Abstract].
FRANK, L. H. and C. RUSHLOW, 1996 A group of genes required for maintenance of the amnioserosa tissue in Drosophila. Development 122:1343-1352[Abstract].
GAVIS, E. R. and R. LEHMANN, 1994 Translational regulation of nanos by RNA localization. Nature 369:315-318[Medline].
GEBAUER, F., L. MERENDINO, M. W. HENTZE, and J. VALCARCEL, 1998 The Drosophila splicing regulator Sex-lethal directly inhibits translation of male-specific-lethal 2 mRNA. RNA 4:142-150[Abstract].
GERGEN, J. P., 1987 Dosage compensation in Drosophila: evidence that daughterless and Sex-lethal control X-chromosome activity at the blastoderm stage of embryogenesis. Genetics 117:477-485
GERGEN, J. P. and E. WIESCHAUS, 1986 Dosage requirements for runt in the segmentation of Drosophila embryos. Cell 45:289-299[Medline].
GUPTA, B. P., G. V. FLORES, U. BANERJEE, and V. RODRIGUES, 1998 Patterning an epidermal field: Drosophila lozenge, a member of the AML-1/Runt family of transcription factors, specifies olfactory sense organ type in a dose-dependent manner. Dev. Biol. 203:400-411[Medline].
GUSTAFSON, K. and G. L. BOULIANNE, 1996 Distinct expression patterns detected within individual tissues by the GAL4 enhancer trap technique. Genome 39:174-182[Medline].
INGHAM, P. and P. GERGEN, 1988 Interactions between the pair-rule genes runt, hairy, even-skipped and fushi tarazu and the establishment of periodic pattern in the Drosophila embryo. Development 104(Suppl.):51-60[Abstract].
ISH-HOROWICZ, D. and S. M. PINCHIN, 1987 Pattern abnormalities induced by ectopic expression of the Drosophila gene hairy are associated with repression of ftz transcription. Cell 51:405-415[Medline].
JOHN, A., S. T. SMITH, and J. B. JAYNES, 1995 Inserting the Ftz homeodomain into engrailed creates a dominant transcriptional repressor that specifically turns off Ftz target genes in vivo. Development 121:1801-1813[Abstract].
KAGOSHIMA, H., K. SHIGESADA, M. SATAKE, Y. ITO, and H. MIYOSHI et al., 1993 The Runt domain identifies a new family of heteromeric transcriptional regulators. Trends Genet. 9:338-341. [letter][Medline].
KELLEY, R. L., I. SOLOVYEVA, L. M. LYMAN, R. RICHMAN, and V. SOLOVYEV et al., 1995 Expression of msl-2 causes assembly of dosage compensation regulators on the X chromosomes and female lethality in Drosophila. Cell 81:867-877[Medline].
KIM-HA, J., K. KERR, and P. M. MACDONALD, 1995 Translational regulation of oskar mRNA by bruno, an ovarian RNA-binding protein, is essential. Cell 81:403-412[Medline].
KLINGLER, M. and J. P. GERGEN, 1993 Regulation of runt transcription by Drosophila segmentation genes. Mech. Dev. 43:3-19[Medline].
KOMORI, T., H. YAGI, S. NOMURA, A. YAMAGUCHI, and K. SASAKI et al., 1997 Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89:755-764. [see comments][Medline].
KRAMER, S. G., T. M. JINKS, P. SCHEDL, and J. P. GERGEN, 1999 Direct activation of Sex-lethal transcription by the Drosophila runt protein. Development 126:191-200[Abstract].
LI, L.-H., 1999 Functional differences in the requirements for interactions of the Runt protein with the Brother proteins and DNA, pp. 162 in Program in Cell and Developmental Biology. SUNY at Stony Brook, Stony Brook, NY.
MACDONALD, P. M. and G. STRUHL, 1988 cis-acting sequences responsible for anterior localization of bicoid mRNA in Drosophila embryos. Nature 336:595-598[Medline].
MANOUKIAN, A. S. and H. M. KRAUSE, 1992 Concentration-dependent activities of the even-skipped protein in Drosophila embryos. Genes Dev. 6:1740-1751
MANOUKIAN, A. S. and H. M. KRAUSE, 1993 Control of segmental asymmetry in Drosophila embryos. Development 118:785-796[Abstract].
MANSEAU, L., A. BARADARAN, D. BROWER, A. BUDHU, and F. ELEFANT et al., 1997 GAL4 enhancer traps expressed in the embryo, larval brain, imaginal discs, and ovary of Drosophila. Dev. Dyn. 209:310-322[Medline].
MARKUSSEN, F. H., A. M. MICHON, W. BREITWIESER, and A. EPHRUSSI, 1995 Translational control of oskar generates short OSK, the isoform that induces pole plasma assembly. Development 121:3723-3732[Abstract].
MATTHEWS, K. A., D. F. MILLER, and T. C. KAUFMAN, 1989 Developmental distribution of RNA and protein products of the Drosophila alpha-tubulin gene family. Dev. Biol. 132:45-61[Medline].
MORRISSEY, D., D. ASKEW, L. RAJ, and M. WEIR, 1991 Functional dissection of the paired segmentation gene in Drosophila embryos. Genes Dev. 5:1684-1696
NÜSSLEIN-VOLHARD, C. and E. WIESCHAUS, 1980 Mutations affecting segment number and polarity in Drosophila. Nature 287:795-801[Medline].
OKUDA, T., J. VAN DEURSEN, S. W. HIEBERT, G. GROSVELD, and J. R. DOWNING, 1996 AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell 84:321-330[Medline].
O'NEILL, E. M., I. REBAY, R. TJIAN, and G. M. RUBIN, 1994 The activities of two Ets-related transcription factors required for Drosophila eye development are modulated by the Ras/MAPK pathway. Cell 78:137-147[Medline].
OTTO, F., A. P. THORNELL, T. CROMPTON, A. DENZEL, and K. C. GILMOUR et al., 1997 Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89:765-771. [see comments][Medline].



